Clinical Trials Action Group (CTAG)

The Clinical Trials Action Group (CTAG) was established to provide advice on reforms to secure Australia’s global competitiveness in the clinical trials sector. This was partly in response to issues raised in the Pharmaceuticals Industry Strategy Group (PISG) Final Report, which was released on 30 January 2009. The CTAG was established as a subgroup of the Pharmaceuticals Industry Working Group (PIWG).

The CTAG sought advice from a wide range of key clinical trials stakeholders from Australian, state and territory governments, hospitals, clinicians, researchers and industry. The CTAG Report Clinically competitive: boosting the business of clinical trials in Australia was released on 3 March 2011.

CTAG Coordination Group

A CTAG Coordination Group (CTAG CG) assisted with implementing the recommendations of the CTAG Report. The CTAG CG had broad representation from the clinical trials sector with state and federal government agencies, industry stakeholders, consumer representatives and researchers as members.

The Group met for the first time on 21 June 2011, and then met regularly until its final meeting in September 2013. Minutes of the meetings are available from the department on request.

Documents developed in response to the CTAG Report recommendations:


Email or write to:
Manager, Biotechnology Section
Advanced Manufacturing Branch
Department of Industry and Science
GPO Box 9839
Canberra ACT 2601

Share this Page